| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/19/2004 | EP1419764A1 Use of an association of synergic calcium channel blocker agents for preventing or treating wrinkles and fine lines |
| 05/19/2004 | EP1419393A1 Tumor specific oligosaccharide sequences and use thereof |
| 05/19/2004 | EP1419257A1 Methylation resistant vectors |
| 05/19/2004 | EP1419241A2 Improved nitroreductase enzymes |
| 05/19/2004 | EP1419175A2 Replikin peptides and uses thereof |
| 05/19/2004 | EP1419173A2 Peptides that bind to atherosclerotic lesions |
| 05/19/2004 | EP1419171A1 Methods for purification of an activated peg solution and for the synthesis of a modified hemoglobin solution |
| 05/19/2004 | EP1419168A2 Antisense modulation of apolipoprotein b expression |
| 05/19/2004 | EP1419163A1 Tricyclic imidazopyridines |
| 05/19/2004 | EP1419162A1 Substituted-aryl 7-aza 2.2.1]bicycloheptanes for the treatment of disease |
| 05/19/2004 | EP1419161A1 Substituted-heteroaryl-7-aza 2.2.1]bicycloheptanes for the treatment of disease |
| 05/19/2004 | EP1419159A1 1-alkyl 0r 1-cycloalkyltriazolo 4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 05/19/2004 | EP1419158A1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 05/19/2004 | EP1419157A2 HETEROCYCLIC COMPOUND BASED ON N sp 6 /sp −SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE |
| 05/19/2004 | EP1419156A1 Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders |
| 05/19/2004 | EP1419155A2 Piperidine derivatives as antibacterial agents |
| 05/19/2004 | EP1419154A1 Rapamycin 29-enols |
| 05/19/2004 | EP1419153A1 Rapamycin dialdehydes |
| 05/19/2004 | EP1419152A1 Hiv inhibiting pyrimidines derivatives |
| 05/19/2004 | EP1419151A1 Chrystals including a malic acid salt of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indole-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| 05/19/2004 | EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 05/19/2004 | EP1419149A1 Benzo g] quinoline derivatives for treating glaucoma and myopia |
| 05/19/2004 | EP1419144A2 Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues |
| 05/19/2004 | EP1419143A1 24-sulfur-substituted analogs of 1alpha,25-dihydroxy vitamin d3 |
| 05/19/2004 | EP1419138A1 N- (1-dimethylaminocycloalkyl)methyl]benzamide derivatives |
| 05/19/2004 | EP1419129A2 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 05/19/2004 | EP1418951A1 Transdermal therapeutic system (tts) with fentanyl as active ingredient |
| 05/19/2004 | EP1418949A2 Inhibitor of dna methylation |
| 05/19/2004 | EP1418937A2 Enhancing organ maturity in neonates and predicting their duration of intensive care |
| 05/19/2004 | EP1418936A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 05/19/2004 | EP1418932A1 An anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration |
| 05/19/2004 | EP1418930A2 Mucosal repair by tff2 peptides |
| 05/19/2004 | EP1418929A2 Simmondsin processing methods and products |
| 05/19/2004 | EP1418925A2 Bioabsorbable adhesive compunds and compositions |
| 05/19/2004 | EP1418924A2 Single dose azithromycin for treating respiratory infections |
| 05/19/2004 | EP1418923A1 Anti-bacterial agents based upon oxoanion binding |
| 05/19/2004 | EP1418922A1 Compositions comprising negatively charched phospholipids for treatment and/or prevention of macular degeneration and method for its manufacture |
| 05/19/2004 | EP1418921A1 Anti-tumour 2-alkoxyestradiol sulfamates |
| 05/19/2004 | EP1418920A1 As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness |
| 05/19/2004 | EP1418919A2 The use of 5 fluorourcil, delivered by inotophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skin |
| 05/19/2004 | EP1418918A2 Compositions and methods for targeting cerebral circulation and treatment of headache |
| 05/19/2004 | EP1418917A1 Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
| 05/19/2004 | EP1418916A1 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer |
| 05/19/2004 | EP1418915A1 Neuroprotective drug |
| 05/19/2004 | EP1418914A2 Mucin synthesis inhibitors |
| 05/19/2004 | EP1418913A1 Substituted urea neuropeptide y y5 receptor antagonists |
| 05/19/2004 | EP1418912A2 Isoxazolopyridinones |
| 05/19/2004 | EP1418911A1 2,4,5-trisubstituted thiazolyl derivatives ant their antiinflammatory activity |
| 05/19/2004 | EP1418910A1 Methods for inhibiting or reversing tau filament formation polymerization |
| 05/19/2004 | EP1418909A2 2-amino-4, 5-trisubstituted thiaolyl derivatives and their use against autoimmune diseases |
| 05/19/2004 | EP1418908A1 Compounds for eliminating and/or relieving anhedonia |
| 05/19/2004 | EP1418907A1 Novel alpha adrenergic agents |
| 05/19/2004 | EP1418906A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 05/19/2004 | EP1418905A1 Therapeutic agent for depletion of an unwanted protein population from plasma |
| 05/19/2004 | EP1418904A2 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 05/19/2004 | EP1418903A2 Prostanoids augment ocular drug penetration |
| 05/19/2004 | EP1418902A1 Novel methods and compositions for the treatment or prevention of dysmenorrhoea and menstrual side effects: the use of phospholipase inhibitors |
| 05/19/2004 | EP1418901A1 The use of anthroquinones in the treatment of kidney disease |
| 05/19/2004 | EP1418900A1 Selective estrogen receptor modulators |
| 05/19/2004 | EP1418899A1 Medicament which can be used for the treatment of cancer |
| 05/19/2004 | EP1418898A1 Use of dmso in the treatment of neurodegenerative diseases caused by prions |
| 05/19/2004 | EP1418897A2 Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer |
| 05/19/2004 | EP1418896A2 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
| 05/19/2004 | EP1418895A1 Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups |
| 05/19/2004 | EP1418894A2 Transdermal therapeutic system with fentanyl or related substances |
| 05/19/2004 | EP1418893A1 Compositions and techniques for localized therapy of restenosis |
| 05/19/2004 | EP1418892A1 Synergistic mixed poloxamer systems for the solubilisation of drugs |
| 05/19/2004 | EP1418891A1 Anaesthetic formulations of propofol |
| 05/19/2004 | EP1418889A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 05/19/2004 | EP1418880A1 Oral rinse for treatment or prevention of bacterial and fungal infection |
| 05/19/2004 | EP1418876A2 Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes, and vascular and renal disorders |
| 05/19/2004 | EP1418869A1 Kavalactone compositions and methods of use |
| 05/19/2004 | EP1418862A2 Individualized addiction cessation therapy |
| 05/19/2004 | EP1418861A2 Methods for treating prostatitis |
| 05/19/2004 | EP1418820A2 Composition with multiple uses for poultry |
| 05/19/2004 | EP1418813A2 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 05/19/2004 | EP1299287A4 Methods of producing a terminally sterilized topical patch preparation |
| 05/19/2004 | EP1289988B1 1,4-diazabicyclo 3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof |
| 05/19/2004 | EP1289987B1 4-(2-phenylthiazol-5-yl)-1,4-diazabicyclo- 3.2.2]nonane derivatives, preparation and therapeutic use thereof |
| 05/19/2004 | EP1273575B1 Diazepane derivatives or salts thereof |
| 05/19/2004 | EP1267869B1 Metabotropic glutamate receptor antagonists for the treatment of tolerance and dependance |
| 05/19/2004 | EP1265618A4 Anaesthetic composition |
| 05/19/2004 | EP1263745B1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase |
| 05/19/2004 | EP1259505B1 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
| 05/19/2004 | EP1235824B1 Vitamin d analogues |
| 05/19/2004 | EP1235555B1 Stable galenic preparations comprising a benzimidazol and method for the production thereof |
| 05/19/2004 | EP1220855B1 Anhydrous salt |
| 05/19/2004 | EP1220849B1 Bicyclic compounds composition and method for stabilizing the same |
| 05/19/2004 | EP1204416A4 Carnitine analogues as topical, microbicidal spermicides |
| 05/19/2004 | EP1200100A4 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration |
| 05/19/2004 | EP1200089B1 Pyridomorphinans and use thereof |
| 05/19/2004 | EP1163523B1 Method for detecting predisposition to a venous thromboembolic disease |
| 05/19/2004 | EP1147084B1 Phenylsulphonyl derivatives as 5-ht receptor ligands |
| 05/19/2004 | EP1131308B1 New piperazine and piperidine compounds |
| 05/19/2004 | EP1128811B1 Drug delivery device, especially for the delivery of progestins and estrogens |
| 05/19/2004 | EP1096922A4 Improved stable topical ascorbic acid compositions |
| 05/19/2004 | EP1086097B1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 05/19/2004 | EP1064294B1 5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them |
| 05/19/2004 | EP1047664B1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 05/19/2004 | EP1041978A4 Methods of inactivating bacteria including bacterial spores |